← Evidence map

ReviewMolecular diversity2026

The cocrystal advantage: overcoming polymorph patent barriers in generic drug development.

Raju G Sharma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41212466